The implications of cost on NOAC selection is considered highly significant for clinicians.
← all excerpts
Novel oral anticoagulants and the 73rd anniversary of historical warfarin.
2
—
—
The sentences
There was a 12% relative risk reduction in the occurrence of stroke and systemic embolism in AF patients treated with rivaroxaban that did not reach statistical significance but was clearly non-inferior to warfarin.